Logo
Search
Home
Podcasts
Archives
Tags
Logo

Archive

Dive into a collection of past posts and rediscover timeless content.

Drug Development

+1

On the same scale: a measurement only travels when it is tied to a shared standard.

Jul 28, 2026

•

3 min read

On the same scale: a measurement only travels when it is tied to a shared standard.

Stefano Gaburro
Stefano Gaburro

Drug Development

+2

A number you can act on: when a method's stated confidence is worth trusting.

Jul 27, 2026

•

3 min read

A number you can act on: when a method's stated confidence is worth trusting.

Szczepan Baran
Szczepan Baran
Read-across, generalized: the transferable evidence pattern hiding in European chemical law.

Jul 21, 2026

•

3 min read

Read-across, generalized: the transferable evidence pattern hiding in European chemical law.

Stefano Gaburro
Stefano Gaburro
Triage the signal: not every preclinical finding deserves a program decision.

Jul 20, 2026

•

3 min read

Triage the signal: not every preclinical finding deserves a program decision.

Szczepan Baran
Szczepan Baran
Weighing, not counting: Europe's weight-of-evidence template for integrating evidence that does not agree.

Jul 19, 2026

•

3 min read

Weighing, not counting: Europe's weight-of-evidence template for integrating evidence that does not agree.

Stefano Gaburro
Stefano Gaburro
Write it down: the one-page decision-context spec a program should carry like a passport.

Jul 19, 2026

•

3 min read

Write it down: the one-page decision-context spec a program should carry like a passport.

Szczepan Baran
Szczepan Baran
A digital preclinical method earns trust the way a bridge does: by being maintained.

Jul 12, 2026

•

3 min read

A digital preclinical method earns trust the way a bridge does: by being maintained.

Stefano Gaburro
Stefano Gaburro
Calibrate: the right dose is a preclinical decision before it is a clinical one.

Jul 11, 2026

•

3 min read

Calibrate: the right dose is a preclinical decision before it is a clinical one.

Szczepan Baran
Szczepan Baran
Adverse outcome pathways are the grammar that lets preclinical evidence travel.

Jul 2, 2026

•

3 min read

Adverse outcome pathways are the grammar that lets preclinical evidence travel.

Stefano Gaburro
Stefano Gaburro
Load more

Digital Record

The weekly newsletter of the Digital Preclinical Society. Application-first coverage of the regulatory shifts, methods, and decisions reshaping preclinical drug development. Free, weekly.


© 2026 Digital Preclinical Society